Predicting HIV-1 Protease and Reverse Transcriptase Drug Resistance Using Fuzzy Cognitive Maps

Several antiviral drugs have been approved for treating HIV infected patients. These drugs inhibit the function of proteins which are essential in the virus life cycle, thus preventing the virus reproduction. However, due to its high mutation rate the HIV is capable to develop resistance to administered therapy. For this reason, it is important to study the resistance mechanisms of the HIV proteins in order to make a better use of existing drugs and design new ones. In the last ten years, numerous statistical and machine learning approaches were applied for predicting drug resistance from protein genome information. In this paper we first review the most relevant techniques reported for addressing this problem. Afterward, we describe a Fuzzy Cognitive Map based modeling which allows representing the causal interactions among the protein positions and their influence on the resistance. Finally, an extended comparison experimentation is carried out, which reveals that this model is competitive with well-known approaches and notably outperforms other techniques from literature.

[1]  Gonzalo Nápoles,et al.  Modelling, Aggregation and Simulation of a Dynamic Biological System through Fuzzy Cognitive Maps , 2012, MICAI.

[2]  Sorin Draghici,et al.  Predicting HIV drug resistance with neural networks , 2003, Bioinform..

[3]  Thomas Lengauer,et al.  Geno2pheno: estimating phenotypic drug resistance from HIV-1 genotypes , 2003, Nucleic Acids Res..

[4]  B. J. Betts,et al.  HIV-1 protease and reverse transcriptase mutation patterns responsible for discordances between genotypic drug resistance interpretation algorithms. , 2003, Journal of acquired immune deficiency syndromes.

[5]  Rubén Fuentes-Fernández,et al.  Advances in Artificial Intelligence – IBERAMIA 2012 , 2012, Lecture Notes in Computer Science.

[6]  Bryan Chan,et al.  Human immunodeficiency virus reverse transcriptase and protease sequence database , 2003, Nucleic Acids Res..

[7]  Robert W. Shafer,et al.  HIV-1 Antiretroviral Resistance , 2012, Drugs.

[8]  Majid Masso,et al.  Prediction of human immunodeficiency virus type 1 drug resistance: Representation of target sequence mutational patterns via an n-grams approach , 2012, 2012 IEEE International Conference on Bioinformatics and Biomedicine.

[9]  A. Vandamme,et al.  A Genotypic Drug Resistance Interpretation Algorithm that Significantly Predicts Therapy Response in HIV-1-Infected Patients , 2001, Antiviral therapy.

[10]  M. Peeters,et al.  Patterns of Resistance Mutations to Antiretroviral Drugs in Extensively Treated HIV‐1‐Infected Patients With Failure of Highly Active Antiretroviral Therapy , 2001, Journal of acquired immune deficiency syndromes.

[11]  Isis Bonet,et al.  Backpropagation through Time Algorithm for Training Recurrent Neural Networks using Variable Length Instances , 2013 .

[12]  R. Shafer,et al.  HIV-1 Protease Mutations and Protease Inhibitor Cross-Resistance , 2010, Antimicrobial Agents and Chemotherapy.

[13]  Yvan Saeys,et al.  Predicting Human Immunodeficiency Virus (HIV) Drug Resistance Using Recurrent Neural Networks , 2006, IWINAC.

[14]  Bart Kosko,et al.  Fuzzy Cognitive Maps , 1986, Int. J. Man Mach. Stud..

[15]  Hans-Paul Schwefel,et al.  Advances in Computational Intelligence , 2003, Natural Computing Series.

[16]  Chunyan Miao,et al.  An Extension to Fuzzy Cognitive Maps for Classification and Prediction , 2011, IEEE Transactions on Fuzzy Systems.

[17]  Matthew Rabinowitz,et al.  Accurate prediction of HIV-1 drug response from the reverse transcriptase and protease amino acid sequences using sparse models created by convex optimization , 2006, Bioinform..

[18]  Gail A. Carpenter,et al.  Neural Network and Bioinformatic Methods for Predicting HIV-1 Protease Inhibitor Resistance , 2007 .

[19]  R. Shafer,et al.  Genotypic predictors of human immunodeficiency virus type 1 drug resistance , 2006, Proceedings of the National Academy of Sciences.

[20]  R. Samudrala,et al.  Simple Linear Model Provides Highly Accurate Genotypic Predictions of HIV-1 Drug Resistance , 2003, Antiviral therapy.

[21]  Thomas Lengauer,et al.  Data and text mining Computational methods for the design of effective therapies against drug resistant HIV strains , 2005 .

[22]  Gonzalo Nápoles,et al.  Fuzzy Cognitive Maps for Modelling, Predicting and Interpreting HIV Drug Resistance , 2012, IBERAMIA.

[23]  R. Shafer,et al.  HIV-1 Antiretroviral Resistance Scientific Principles and Clinical Applications , 2012 .

[24]  José R. Álvarez,et al.  Bio-inspired Modeling of Cognitive Tasks, Second International Work-Conference on the Interplay Between Natural and Artificial Computation, IWINAC 2007, La Manga del Mar Menor, Spain, June 18-21, 2007, Proceedings, Part I , 2007, IWINAC.

[25]  Isis Bonet,et al.  Multi-classifier based on hard instances- new method for prediction of human immunodeficiency virus drug resistance. , 2013, Current topics in medicinal chemistry.

[26]  Takeaki Uno,et al.  Mining complex genotypic features for predicting HIV-1 drug resistance , 2007, Bioinform..

[27]  R. Jernigan,et al.  Self‐consistent estimation of inter‐residue protein contact energies based on an equilibrium mixture approximation of residues , 1999, Proteins.

[28]  Boonserm Kijsirikul,et al.  The application of artificial neural networks for phenotypic drug resistance prediction: evaluation and comparison with other interpretation systems. , 2010, Japanese journal of infectious diseases.